<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="inject drugsSubst. Use Misuse2016511218122310.3109/10826084.2016.116105427219274 2.DoreG.J.ConwayB.LuoY.JanczewskaE.KnyszB.LiuY.PodsadeckiT.Efficacy and safety of ombitasvir/paritaprevir/r and" exact="dasabuvir" post="compared to IFN-containing regimens in genotype 1 HCV patients:"/>
 <result pre="drug use: An integrated analysis of 7 phase III studiesDrug" exact="Alcohol" post="Depend.201919448749410.1016/j.drugalcdep.2018.11.00730529905 21.HuangM.LiuW.SuL.WuC.WuP.YangS.ChangS.Hepatitis C virus re-infection after viral clearance of"/>
 <result pre="regimensLiver Int.20183882183310.1111/liv.1359628941023 25.RockstrohJ.K.OrkinC.VianiR.M.WylesD.LuetkemeyerA.F.LazzarinA.LazzarinA.Soto-MalaveR.NelsonM.R.BhaganiS.R.et al.Safety and efficacy of ombitasvir, paritaprevir with" exact="ritonavir" post="Â± dasabuvir with or without ribavirin in patients with"/>
 <result pre="25.RockstrohJ.K.OrkinC.VianiR.M.WylesD.LuetkemeyerA.F.LazzarinA.LazzarinA.Soto-MalaveR.NelsonM.R.BhaganiS.R.et al.Safety and efficacy of ombitasvir, paritaprevir with ritonavir Â±" exact="dasabuvir" post="with or without ribavirin in patients with human immunodeficiency"/>
 <result pre="of ombitasvir, paritaprevir with ritonavir Â± dasabuvir with or without" exact="ribavirin" post="in patients with human immunodeficiency virus-1 and hepatitis C"/>
 <result pre="Time(Participant Range if Given) Attrition Rate (Loss to Follow-Up) 1" exact="Foster" post="et al., 2019 [20] Integrated analysis of clinical trials"/>
</results>
